Joint infectious causation of human cancers

Advances in Parasitology

Volumn 84, Issue , 2014, Pages 1-26

  Ewald, Paul W ^a   Swain Ewald, Holly A ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Barriers; Cancer; Coinfection; Evolution; Infection; Oncogenesis; Prevention; Vaccination

Indexed keywords

TELOMERASE;

APOPTOSIS; ARTICLE; ASYMMETRIC CELL DIVISION; BREAST CANCER; BURKITT LYMPHOMA; CANCER CONTROL; CARCINOGENESIS; CELL ADHESION; CELL CYCLE ARREST; CELL IMMORTALIZATION; CELL SURVIVAL; CELL TRANSFORMATION; DELTA AGENT HEPATITIS; DISEASE EXACERBATION; ENDOGENOUS RETROVIRUS; HELICOBACTER PYLORI; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HOST CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTIOUS ARTHRITIS; LIVER CANCER; MALARIA FALCIPARUM; MARGINAL ZONE LYMPHOMA; MIXED INFECTION; NEOPLASM; NEOPLASMS OF UNCERTAIN BEHAVIOR; PAPILLOMAVIRUS INFECTION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SALMONELLA; STOMACH CANCER; TREMATODE; TREMATODIASIS; UTERINE CERVIX CANCER;

BARRIERS; CANCER; COINFECTION; EVOLUTION; INFECTION; ONCOGENESIS; PREVENTION; VACCINATION;

ANIMALS; HOST-PATHOGEN INTERACTIONS; HUMANS; NEOPLASMS;

EID: 84893022281     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800099-1.00001-6     Document Type: Chapter

References (134)

1. Afzan M.Y., Suresh K. Pseudocyst forms of Trichomonas vaginalis from cervical neoplasia. Parasitol. Res. 2012, 111:371-381.
2. Anwar W.A. Praziquantel (antischistosomal drug): is it clastogenic, co-clastogenic or anticlastogenic. Mutat. Res. 1994, 305:165-173.
3. Ashktorab H., Daremipouran M., Wilson M., Siddiqi S., Lee E.L., Rakhshani N., Malekzadeh R., Johnson A.C., Hewitt S.M., Smoot D.T. Transactivation of the EGFR by AP-1 is induced by Helicobacter pylori in gastric cancer. Am. J. Gastroenterol. 2007, 102:2135-2146.
4. Badawi H., Ahmed H., Ismail A., Diab M., Moubarak M., Badawy A., Saber M. Role of human papillomavirus types 16, 18, and 52 in recurrent cystitis and urinary bladder cancer among Egyptian patients. Medscape J. Med. 2008, 10:232.
5. Badawi H., Ahmed H., Aboul Fadl L., Helmi A., Fam N., Diab M., Ismail A., Badawi A., Saber M. Herpes simplex virus type-2 in Egyptian patients with bladder cancer or cystitis. APMIS 2010, 118:37-44.
6. Barghi M.R., Rahjoo T., Borghei M., Hosseini-Moghaddam S.M., Amani D., Farrokhi B. Association between the evidence of human papilloma virus infection in bladder transitional cell carcinoma in men and cervical dysplasia in their spouses. Arch. Iran. Med. 2012, 15:572-574.
7. Bearss D.J., Lee R.J., Troyer D.A., Pestell R.G., Windle J.J. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties. Cancer Res. 2002, 62:2077-2084.
8. Bernstein W.B., Little R.F., Wilson W.H., Yarchoan R. Acquired immunodeficiency syndrome-related malignancies in the era of highly active antiretroviral therapy. Int. J. Hematol. 2006, 84:3-11.
9. Bhadra S., Lozano M.M., Payne S.M., Dudley J.P. Endogenous MMTV proviruses induce susceptibility to both viral and bacterial pathogens. PLoS Pathog. 2006, 2:e128.
10. Bhandari A., Crowe S.E. Helicobacter pylori in gastric malignancies. Curr. Gastroenterol. Rep. 2012, 14:489-496.
11. Bhatia K., Shiels M.S., Berg A., Engels E.A. Sarcomas other than Kaposi sarcoma occurring in immunodeficiency: interpretations from a systematic literature review. Curr. Opin. Oncol. 2012, 24:537-546.
12. Bittner J.J. The Milk-Influence of Breast Tumors in Mice. Science 1942, 95:462-463.
13. Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., Benbrahim-Tallaa L., Guha N., Freeman C., Galichet L., Cogliano V. A review of human carcinogens-part B: biological agents. Lancet Oncol. 2009, 10:321-322.
14. Buehring G.C., Shen H.M., Jensen H.M., Block G. Bovine leukemia virus infection is significantly associated with risk of breast cancer. Proc. Am. Assoc. Cancer Res. 2007, 48:1747.
15. Burkitt D. A sarcoma involving the jaws in African children. Br. J. Surg. 1958, 46:218-223.
16. Carpenter L.M., Newton R., Casabonne D., Ziegler J., Mbulaiteye S., Mbidde E., Wabinga H., Jaffe H., Beral V. Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda. Int. J. Cancer 2008, 122:1319-1323.
17. Caulin A.F., Maley C.C. Peto's Paradox: evolution's prescription for cancer prevention. Trends Ecol. Evol. 2011, 26:175-182.
18. Chang M.H., You S.L., Chen C.J., Liu C.J., Lee C.M., Lin S.M., Chu H.C., Wu T.C., Yang S.S., Kuo H.S., Chen D.S., Taiwan Hepatoma Study Group Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J. Natl. Cancer Inst. 2009, 101:1348-1355.
19. Chaux A., Cubilla A.L. The role of human papillomavirus infection in the pathogenesis of penile squamous cell carcinomas. Semin. Diagn. Pathol. 2012, 29:67-71.
20. Chêne A., Donati D., Guerreiro-Cacais A.O., Levitsky V., Chen Q., Falk K.I., Orem J., Kironde F., Wahlgren M., Bejarano M.T. A molecular link between malaria and Epstein-Barr virus reactivation. PLoS Pathog. 2007, 3:e80.
21. Chêne A., Donati D., Orem J., Mbidde E.R., Kironde F., Wahlgren M., Bejarano M.T. Endemic Burkitt's lymphoma as a polymicrobial disease: new insights on the interaction between Plasmodium falciparum and Epstein-Barr virus. Semin. Cancer Biol. 2009, 19:411-420.
22. Cheng A.S., Li M.S., Kang W., Cheng V.Y., Chou J.L., Lau S.S., Go M.Y., Lee C.C., Ling T.K., Ng E.K., Yu J., Huang T.H., To K.F., Chan M.W., Sung J.J., Chan F.K. Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis. Gastroenterology 2013, 144:122-133.
23. Chiao E.Y., Krown S.E. Update on non-acquired immunodeficiency syndrome-defining malignancies. Curr. Opin. Oncol. 2003, 15:389-397.
24. Cho L.Y., Yang J.J., Ko K.P., Park B., Shin A., Lim M.K., Oh J.K., Park S., Kim Y.J., Shin H.R., Yoo K.Y., Park S.K. Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: systematic review and meta-analysis. Int. J. Cancer 2011, 128:176-184.
25. Chung I.K., Hwang K.Y., Kim I.H., Kim H.S., Park S.H., Lee M.H., Kim C.J., Kim S.J. Helicobacter pylori and telomerase activity in intestinal metaplasia of the stomach. Korean J. Intern. Med. 2002, 17:227-233.
26. Damin A.P., Karam R., Zettler C.G., Caleffi M., Alexandre C.O. Evidence for an association of human papillomavirus and breast carcinomas. Breast Cancer Res. Treat. 2004, 84:131-137.
27. de Martel C., Ferlay J., Franceschi S., Vignat J., Bray F., Forman D., Plummer M. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012, 13:607-615.
28. Deen N.S., Huang S.J., Gong L., Kwok T., Devenish R.J. The impact of autophagic processes on the intracellular fate of Helicobacter pylori: more tricks from an enigmatic pathogenα. Autophagy 2013, 9:639-652.
29. DeGregori J. Evolved tumor suppression: why are we so good at not getting cancerα. Cancer Res. 2011, 71:3739-3744.
30. De Paoli P., Pratesi C., Bortolin M.T. The Epstein Barr virus DNA levels as a tumor marker in EBV-associated cancers. J. Cancer Res. Clin. Oncol. 2007, 133:809-815.
31. Donato F., Gelatti U., Tagger A., Favret M., Ribero M.L., Callea F., Martelli C., Savio A., Trevisi P., Nardi G. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer Causes Control 2001, 12:959-964.
32. Epstein M.A. The origins of EBV research: discovery and characterization of the virus. Epstein-Barr Virus 2005, 1-14. Caister Academic Press, Norfolk, UK. E.S. Robertson (Ed.).
33. Epstein M.A., Achong B.G., Barr Y.M. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964, 1:702-703.
34. Ewald P.W. An evolutionary perspective on parasitism as a cause of cancer. Adv. Parasitol. 2009, 68:21-43.
35. Ewald P.W., Swain Ewald H.A. Evolutionary insights for immunological interventions. Pragmatic Evolution 2011, 115-132. Cambridge University Press, Cambridge. A. Poiani (Ed.).
36. Ewald P.W., Swain Ewald H.A. Infection, mutation, and cancer evolution. J. Mol. Med. (Berl.) 2012, 90:535-541.
37. Ewald P.W., Swain Ewald H.A. Toward a general evolutionary theory of oncogenesis. Evol. Appl. 2013, 6:70-81.
38. Fattovich G., Giustina G., Christensen E., Pantalena M., Zagni I., Realdi G., Schalm S.W. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep). Gut 2000, 46:420-426.
39. Ferreri A.J., Ernberg I., Copie-Bergman C. Infectious agents and lymphoma development: molecular and clinical aspects. J. Intern. Med. 2009, 265:421-438.
40. Fioriti D., Pietropaolo V., Dal Forno S., Laurenti C., Chiarini F., Degener A.M. Urothelial bladder carcinoma and viral infections: different association with human polyomaviruses and papillomaviruses. Int. J. Immunopathol. Pharmacol. 2003, 16:283-288.
41. Frisch M. On the etiology of anal squamous carcinoma. Dan. Med. Bull. 2002, 49:194-209.
42. Gazzaniga P., Vercillo R., Gradilone A., Silvestri I., Gandini O., Napolitano M., Giuliani L., Fioravanti A., Gallucci M., Agliano A.M. Prevalence of papillomavirus, Epstein-Barr virus, cytomegalovirus, and herpes simplex virus type 2 in urinary bladder cancer. J. Med. Virol. 1998, 55:262-267.
43. Geissler C., Tahtali A., Diensthuber M., Gassner D., Stover T., Wagenblast J. The role of p16 expression as a predictive marker in HPV-positive oral SCCHN-a retrospective single-center study. Anticancer Res. 2013, 33:913-916.
44. Gelfand M., Weinberg R.W., Castle W.M. Relation between carcinoma of the bladder and infestation with Schistosoma haematobium. Lancet 1967, 1:1249-1251.
45. Gisbert J.P., Calvet X. Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma. Aliment. Pharmacol. Ther. 2011, 34:1047-1062.
46. Glenn W.K., Heng B., Delprado W., Iacopetta B., Whitaker N.J., Lawson J.S. Epstein-Barr virus, human papillomavirus and mouse mammary tumour virus as multiple viruses in breast cancer. PLoS One 2012, 7:e48788.
47. Gross L. "Spontaneous" leukemia developing in C3H mice following inoculation in infancy, with AK-leukemic extracts, or AK-embrvos. Proc. Soc. Exp. Biol. Med. 1951, 76:27-32.
48. Grulich A.E., van Leeuwen M.T., Falster M.O., Vajdic C.M. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007, 370:59-67.
49. Hachana M., Amara K., Ziadi S., Gacem R.B., Korbi S., Trimeche M. Investigation of human JC and BK polyomaviruses in breast carcinomas. Breast Cancer Res. Treat. 2012, 133:969-977.
50. Hennig E.M., Suo Z., Thoresen S., Holm R., Kvinnsland S., Nesland J.M. Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III). Breast Cancer Res. Treat. 1999, 53:121-135.
51. Hou P. The relationship between primary carcinoma of the liver and infestation with Clonorchis sinensis. J. Pathol. Bacteriol. 1956, 72:239-246.
52. Hu S., Yang L., Wu Z., Wong C.S., Fung M.C. Suppression of adaptive immunity to heterologous antigens by SJ16 of Schistosoma japonicum. J. Parasitol. 2012, 98:274-283.
53. Hur K., Gazdar A.F., Rathi A., Jang J.J., Choi J.H., Kim D.Y. Overexpression of human telomerase RNA in Helicobacter pylori-infected human gastric mucosa. Jpn. J. Cancer Res. 2000, 91:1148-1153.
54. Husain E., Prowse D.M., Ktori E., Shaikh T., Yaqoob M., Junaid I., Baithun S. Human papillomavirus is detected in transitional cell carcinoma arising in renal transplant recipients. Pathology 2009, 41:245-247.
55. Johal H., Scott G.M., Jones R., Camaris C., Riordan S., Rawlinson W.D. Mouse mammary tumour virus-like virus (MMTV-LV) is present within the liver in a wide range of hepatic disorders and unrelated to nuclear p53 expression or hepatocarcinogenesis. J. Hepatol. 2009, 50:548-554.
56. Joshi D., Buehring G.C. Are viruses associated with human breast cancerα Scrutinizing the molecular evidence. Breast Cancer Res. Treat. 2012, 135:1-15.
57. Kafuko G.W., Burkitt D.P. Burkitt's lymphoma and malaria. Int. J. Cancer 1970, 6:1-9.
58. Kameshima H., Yagihashi A., Yajima T., Kobayashi D., Denno R., Hirata K., Watanabe N. Helicobacter pylori infection: augmentation of telomerase activity in cancer and noncancerous tissues. World J. Surg. 2000, 24:1243-1249.
59. Katz E., Lareef M.H., Rassa J.C., Grande S.M., King L.B., Russo J., Ross S.R., Monroe J.G. MMTV Env encodes an ITAM responsible for transformation of mammary epithelial cells in three-dimensional culture. J. Exp. Med. 2005, 201:431-439.
60. Kim K.H., Kim Y.S. Analysis of p53 tumor suppressor gene mutations and human papillomavirus infection in human bladder cancers. Yonsei Med. J. 1995, 36:322-331.
61. Kim H.H., Grande S.M., Monroe J.G., Ross S.R. Mouse mammary tumor virus suppresses apoptosis of mammary epithelial cells through ITAM-mediated signaling. J. Virol. 2012, 86:13232-13240.
62. Kimura H., Ito Y., Suzuki R., Nishiyama Y. Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease. Rev. Med. Virol. 2008, 18:305-319.
63. Kroupis C., Markou A., Vourlidis N., Dionyssiou-Asteriou A., Lianidou E.S. Presence of high-risk human papillomavirus sequences in breast cancer tissues and association with histopathological characteristics. Clin. Biochem. 2006, 39:727-731.
64. Kuo S.H., Yeh K.H., Wu M.S., Lin C.W., Hsu P.N., Wang H.P., Chen L.T., Cheng A.L. Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas. Blood 2012, 119:4838-4844. quiz 5057.
65. Lawson J.S., Heng B. Viruses and breast cancer. Cancers 2010, 2:752-772.
66. Lawson J.S., Glenn W.K., Salmons B., Ye Y., Heng B., Moody P., Johal H., Rawlinson W.D., Delprado W., Lutze-Mann L., Whitaker N.J. Mouse mammary tumor virus-like sequences in human breast cancer. Cancer Res. 2010, 70:3576-3585.
67. Lax A.J., Thomas W. How bacteria could cause cancer: one step at a time. Trends Microbiol. 2002, 10:293-299.
68. Lee T.Y., Lee S.S., Jung S., Jeon S.H., Yun S.C., Oh H.C., Kwon S., Lee S.K., Seo D.W., Kim M.H., Suh D.J. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study. Am. J. Gastroenterol. 2008, 103:1716-1720.
69. Lu Y., Gu J., Jin D., Gao Y., Yuan M. Inhibition of telomerase activity by HDV ribozyme in cancers. J. Exp. Clin. Cancer Res. 2011, 30:1.
70. Manson-Bahr P.E.C., Apted F.I.C. Manson's Tropical Diseases 1982, Bailliere Tindall, London.
71. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008, 454:436-444.
72. Marty R., Roze S., Bresse X., Largeron N., Smith-Palmer J. Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe. BMC Cancer 2013, 13:10.
73. Mbulaiteye S.M., Talisuna A.O., Ogwang M.D., McKenzie F.E., Ziegler J.L., Parkin D.M. African Burkitt's lymphoma: could collaboration with HIV-1 and malaria programmes reduce the high mortality rateα. Lancet 2010, 375:1661-1663.
74. Mbulaiteye S.M., Pullarkat S.T., Nathwani B.N., Weiss L.M., Nagesh R., Emmanuel B., Lynch C.F., Hernandez B., Neppalli V., Hawes D., Cockburn M.G., Kim A., Williams M., Altekruse S., Bhatia K., Goodman M.T., Cozen W. Epstein-Barr virus patterns in US Burkitt lymphoma tumors from the SEER residual tissue repository during 1979-2009. APMIS 2013, [Epub ahead of print].
75. Mbulaiteye S.M., Clarke C.A., Morton L.M., Gibson T.M., Pawlish K., Weisenburger D.D., Lynch C.F., Goodman M.T., Engels E.A. Burkitt lymphoma risk in U.S. solid organ transplant recipients. Am. J. Hematol. 2013, 88:245-250.
76. McClain K.L., Leach C.T., Jenson H.B., Joshi V.V., Pollock B.H., Parmley R.T., DiCarlo F.J., Chadwick E.G., Murphy S.B. Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. N. Engl. J. Med. 1995, 332:12-18.
77. McColl K.E. Clinical practice. Helicobacter pylori infection. N. Engl. J. Med. 2010, 362:1597-1604.
78. Michaelson J.S., Leder P. Beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland. Oncogene 2001, 20:5093-5099.
79. Molyneux E.M., Rochford R., Griffin B., Newton R., Jackson G., Menon G., Harrison C.J., Israels T., Bailey S. Burkitt's lymphoma. Lancet 2012, 379:1234-1244.
80. Moss S.F., Blaser M.J. Mechanisms of disease: inflammation and the origins of cancer. Nature clinical practice. Oncology 2005, 2:90-97. quiz 91 p following 113.
81. Moonen P.M., Bakkers J.M., Kiemeney L.A., Schalken J.A., Melchers W.J., Witjes J.A. Human papilloma virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer. Eur. Urol. 2007, 52:464-468.
82. Mostafa M.J., Sheweita S.A., O'Connor P.J. Relationship between schistosomiasis and bladder cancer. Clin. Microbiol. Rev. 1999, 12:97-111.
83. Mustacchi P., Shimkin M.B. Cancer of the bladder and infestation with Schistosoma hematobium. J. Natl. Cancer Inst. 1958, 20:825-842.
84. Mutalima N., Molyneux E., Jaffe H., Kamiza S., Borgstein E., Mkandawire N., Liomba G., Batumba M., Lagos D., Gratrix F., Boshoff C., Casabonne D., Carpenter L.M., Newton R. Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case-control study. PLoS One 2008, 3:e2505.
85. Nakamura S., Sugiyama T., Matsumoto T., Iijima K., Ono S., Tajika M., Tari A., Kitadai Y., Matsumoto H., Nagaya T., Kamoshida T., Watanabe N., Chiba T., Origasa H., Asaka M. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Gut 2012, 61:507-513.
86. Nath G., Gulati A.K., Shukla V.K. Role of bacteria in carcinogenesis, with special reference to carcinoma of the gallbladder. World J. Gastroenterol. 2010, 16:5395-5404.
87. Niehrs C., Acebron S.P. Mitotic and mitogenic Wnt signalling. EMBO J. 2012, 31:2705-2713.
88. Niro G.A., Smedile A. Current concept in the pathophysiology of hepatitis delta infection. Curr. Infect. Dis. Rep. 2012, 14:9-14.
89. No J.H., Kim M.K., Jeon Y.T., Kim Y.B., Song Y.S. Human papillomavirus vaccine: widening the scope for cancer prevention. Mol. Carcinog. 2011, 50:244-253.
90. Noel J.C., Thiry L., Verhest A., Deschepper N., Peny M.O., Sattar A.A., Schulman C.C., Haot J. Transitional cell carcinoma of the bladder: evaluation of the role of human papillomaviruses. Urology 1994, 44:671-675.
91. Oh J.K., Shin H.R., Lim M.K., Cho H., Kim D.I., Jee Y., Yun H., Yoo K.Y. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study. BMC Cancer 2012, 12:452.
92. Oldani A., Cormont M., Hofman V., Chiozzi V., Oregioni O., Canonici A., Sciullo A., Sommi P., Fabbri A., Ricci V., Boquet P. Helicobacter pylori counteracts the apoptotic action of its VacA toxin by injecting the CagA protein into gastric epithelial cells. PLoS Pathog. 2009, 5:e1000603.
93. Orem J., Mbidde E.K., Lambert B., de Sanjose S., Weiderpass E. Burkitt's lymphoma in Africa, a review of the epidemiology and etiology. Afr. Health Sci. 2007, 7:166-175.
94. Ouatas T., Clare S.E., Hartsough M.T., De La Rosa A., Steeg P.S. MMTV-associated transcription factor binding sites increase nm23-H1 metastasis suppressor gene expression in human breast carcinoma cell lines. Clin. Exp. Metastasis 2002, 19:35-42.
95. Panagiotakis G.I., Papadogianni D., Chatziioannou M.N., Lasithiotaki I., Delakas D., Spandidos D.A. Association of human herpes, papilloma and polyoma virus families with bladder cancer. Tumour Biol. 2013, 34:71-79.
96. Perkins R.S., Sahm K., Marando C., Dickson-Witmer D., Pahnke G.R., Mitchell M., Petrelli N.J., Berkowitz I.M., Soteropoulos P., Aris V.M., Dunn S.P., Krueger L.J. Analysis of Epstein-Barr virus reservoirs in paired blood and breast cancer primary biopsy specimens by real time PCR. Breast Cancer Res. 2006, 8:R70.
97. Perrigoue J.G., den Boon J.A., Friedl A., Newton M.A., Ahlquist P., Sugden B. Lack of association between EBV and breast carcinoma. Cancer Epidemiol. Biomarkers Prev. 2005, 14:809-814.
98. Rabson A.S., Kirschstein R.L. Induction of malignancy in vitro in newborn hamster kidney tissue infected with simian vacuolating virus (SV40). Proc. Soc. Exp. Biol. Med. 1962, 111:323-328.
99. Rochford R., Cannon M.J., Moormann A.M. Endemic Burkitt's lymphoma: a polymicrobial diseaseα. Nat. Rev. Microbiol. 2005, 3:182-187.
100. Romanish M.T., Cohen C.J., Mager D.L. Potential mechanisms of endogenous retroviral-mediated genomic instability in human cancer. Semin. Cancer Biol. 2010, 20:246-253.
101. Rosenquist K. Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Swed. Dent. J. Suppl. 2005, 1-66.
102. Ross S.R., Schmidt J.W., Katz E., Cappelli L., Hultine S., Gimotty P., Monroe J.G. An immunoreceptor tyrosine activation motif in the mouse mammary tumor virus envelope protein plays a role in virus-induced mammary tumors. J. Virol. 2006, 80:9000-9008.
103. Ross S.R. Mouse mammary tumor virus molecular biology and oncogenesis. Viruses 2010, 2:2000-2012.
104. Rous P. A transmissible avian neoplasm (Sarcoma of the common fowl.). J. Exp. Med. 1910, 12:696-705.
105. Rous P. A Sarcoma of the fowl transmissible by an agent separable from the tumor cells. J. Exp. Med. 1911, 13:397-411.
106. Rowlands T.M., Pechenkina I.V., Hatsell S., Cowin P. Beta-catenin and cyclin D1: connecting development to breast cancer. Cell Cycle 2004, 3:145-148.
107. Ruprecht K., Mayer J., Sauter M., Roemer K., Mueller-Lantzsch N. Endogenous retroviruses and cancer. Cell. Mol. Life Sci. 2008, 65:3366-3382.
108. Salmons B., Gunzburg W.H. Revisiting a role for a mammary tumor retrovirus in human breast cancer. Int. J. Cancer 2013, 133:1530-1535.
109. Samaras V., Rafailidis P.I., Mourtzoukou E.G., Peppas G., Falagas M.E. Chronic bacterial and parasitic infections and cancer: a review. J. Infect. Dev. Ctries. 2010, 4:267-281.
110. Sano T., Sakurai S., Fukuda T., Nakajima T. Unsuccessful effort to detect human papillomavirus DNA in urinary bladder cancers by the polymerase chain reaction and in situ hybridization. Pathol. Int. 1995, 45:506-512.
111. Seluanov A., Hine C., Bozzella M., Hall A., Sasahara T.H., Ribeiro A.A., Catania K.C., Presgraves D.C., Gorbunova V. Distinct tumor suppressor mechanisms evolve in rodent species that differ in size and lifespan. Aging Cell 2008, 7:813-823.
112. Shaib Y., El-Serag H., Davila J., Morgan R., McGlynn K. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 2005, 128:620-626.
113. Shaib Y.H., EI-Serag H.B., Nooka A.K., Thomas M., Brown T.D., Patt Y.Z., Hassan M.M. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am. J. Gastroenterol. 2007, 102:1016-1021.
114. Shope R.E., Hurst E.W. Infectious papillomatosis of rabbits: with a note on the histopathology. J. Exp. Med. 1933, 58:607-624.
115. Simoes P.W., Medeiros L.R., Simoes Pires P.D., Edelweiss M.I., Rosa D.D., Silva F.R., Silva B.R., Rosa M.I. Prevalence of human papillomavirus in breast cancer: a systematic review. Int. J. Gynecol. Cancer 2012, 22:343-347.
116. Snider C.J., Cole S.R., Chelimo K., Sumba P.O., Macdonald P.D., John C.C., Meshnick S.R., Moormann A.M. Recurrent Plasmodium falciparum malaria infections in Kenyan children diminish T-cell immunity to Epstein Barr virus lytic but not latent antigens. PLoS One 2012, 7:e31753.
117. Stoye J.P. Studies of endogenous retroviruses reveal a continuing evolutionary saga. Nat. Rev. Microbiol. 2012, 10:395-406.
118. Suzuki M., Mimuro H., Kiga K., Fukumatsu M., Ishijima N., Morikawa H., Nagai S., Koyasu S., Gilman R.H., Kersulyte D., Berg D.E., Sasakawa C. Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell Host Microbe 2009, 5:23-34.
119. Taylor J.M. Hepatitis delta virus. Virology 2006, 344:71-76.
120. Thomas F., Lafferty K.D., Brodeur J., Elguero E., Gauthier-Clerc M., Misse D. Incidence of adult brain cancers is higher in countries where the protozoan parasite Toxoplasma gondii is common. Biol. Lett. 2012, 8:101-103.
121. Trinchieri G. Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annu. Rev. Immunol. 2012, 30:677-706.
122. van Leeuwen M.T., Vajdic C.M., Middleton M.G., McDonald A.M., Law M., Kaldor J.M., Grulich A.E. Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy. AIDS 2009, 23:2183-2190.
123. Vereide D., Sugden B. Proof for EBV's sustaining role in Burkitt's lymphomas. Semin. Cancer Biol. 2009, 19:389-393.
124. Vereide D.T., Seto E., Chiu Y.F., Hayes M., Tagawa T., Grundhoff A., Hammerschmidt W., Sugden B. Epstein-Barr virus maintains lymphomas via its miRNAs. Oncogene 2013, [Epub ahead of print].
125. Wang D., Pearlberg J., Liu Y.T., Ganem D. Deleterious effects of hepatitis delta virus replication on host cell proliferation. J. Virol. 2001, 75:3600-3604.
126. Wang P., Mei J., Tao J., Zhang N., Tian H., Fu G.H. Effects of Helicobacter pylori on biological characteristics of gastric epithelial cells. Histol. Histopathol. 2012, 27:1079-1091.
127. Wang T., Chang P., Wang L., Yao Q., Guo W., Chen J., Yan T., Cao C. The role of human papillomavirus infection in breast cancer. Med. Oncol. 2012, 29:48-55.
128. Yavuzer D., Karadayi N., Salepci T., Baloglu H., Bilici A., Sakirahmet D. Role of human papillomavirus in the development of urothelial carcinoma. Med. Oncol. 2011, 28:919-923.
129. Young G.R., Kassiotis G., Stoye J.P. Emv2, the only endogenous ecotropic murine leukemia virus of C57BL/6J mice. Retrovirology 2012, 9:23.
130. Youshya S., Purdie K., Breuer J., Proby C., Sheaf M.T., Oliver R.T., Baithun S. Does human papillomavirus play a role in the development of bladder transitional cell carcinomaα A comparison of PCR and immunohistochemical analysis. J. Clin. Pathol. 2005, 58:207-210.
131. Zhang Z.F., Begg C.B. Is Trichomonas vaginalis a cause of cervical neoplasiaα Results from a combined analysis of 24 studies. Int. J. Epidemiol. 1994, 23:682-690.
132. Zhou Y.M., Yin Z.F., Yang J.M., Li B., Shao W.Y., Xu F., Wang Y., Li D.Q. Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China. World J. Gastroenterol. 2008, 14:632-635.
133. zur Hausen H. Papillomaviruses-to vaccination and beyond. Biochemistry (Mosc.) 2008, 73:498-503.
134. zur Hausen H. Infections Causing Human Cancer 2010, Wiley-VCH, Weinheim, Germany.